The 20th anniversary edition of BIO-Europe® international partnering conference wrapped up last week, November 3–5, in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center.
The conference attracted over 3,200 leading dealmakers from 54 countries comprising 1,786 companies made up of biotech, large and midsize pharma, and finance along with emerging companies. There were approximately 18,000 one-to-one partnering meetings and 4,065 licensing opportunities on offer, an all-time record. In addition, there were 162 company presentations and 98 exhibitors at the event.
BIO-Europe is a unique industry event, where delegates from all parts of the biotechnology value chain come to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful and historic business partnerships that resulted in life-saving drugs for patients.
“This year marked the 20th anniversary of BIO-Europe, and it was our most successful event to date in terms of the caliber of attendees, the number of partnering meetings and the sheer volume of licensing opportunities brought to the table,” said Anna Chrisman, Group Managing Director, EBD Group.
“As the home of Europe’s first biotech entrepreneur, Dr. Emil von Behring, it made sense for the 20th anniversary of BIO-Europe to take place in Hessen,” said Dr. Rainer Waldschmidt, the CEO of Hessen Trade & Invest. “Frankfurt is an ideal location for drug development companies, and we were pleased to welcome a vast array of biotech and large pharma industry leaders to experience Frankfurt’s strength in and dedication to life science innovation.”
Next year’s BIO-Europe event will be held November 2–4, 2015 in Munich, Germany.
Video coverage and exclusive interviews from BIO-Europe are available on the BIO-Europe web site and on partnering360®. BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry.
At BIO-Europe, companies participated in one-to-one partnering meetings facilitated by EBD Group’s highly reputable partneringONE® platform.
About BIO-Europe® 2014:
BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry.
Delegates from all parts of the biotechnology value chain attended BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships.
Join conversations about BIO-Europe 2014 on Twitter: twitter.com/ebdgroup (hashtag: #BEU14). Or log on to the Life Science Partnering discussion forum on partnering360. The Group is your go-to discussion forum for news and topics related to BIO-Europe.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
+1 760 930 0500